Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology (Q38683683)

5 September 2017

Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology (English)

1 reference

mild cognitive impairment

5 September 2017

0 references

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author

Alzheimer's Disease Neuroimaging Initiative

13

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

5 September 2017

12

Ariel Graff-Guerrero

0 references

author name string

Jun Ku Chung

1

1 reference

5 September 2017

Eric Plitman

2

1 reference

5 September 2017

Shinichiro Nakajima

3

1 reference

5 September 2017

Fernando Caravaggio

4

1 reference

5 September 2017

Yusuke Iwata

5

1 reference

5 September 2017

Philip Gerretsen

6

1 reference

5 September 2017

Julia Kim

7

1 reference

5 September 2017

Hiroyoshi Takeuchi

8

1 reference

5 September 2017

Shunichiro Shinagawa

9

1 reference

5 September 2017

Raihaan Patel

10

1 reference

5 September 2017

M Mallar Chakravarty

11

1 reference

5 September 2017

8 May 2017

1 reference

Journal of Alzheimer's Disease

5 September 2017

1 reference

5 September 2017

58

1 reference

5 September 2017

747-762

1 reference

5 September 2017

3

1 reference

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

5 September 2017

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Association of hypometabolism and amyloid levels in aging, normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Alzheimer's disease and the amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Suspected non-Alzheimer disease pathophysiology--concept and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Suspected non-AD pathology in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Brain injury biomarkers are not dependent on β-amyloid in normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Predicting Alzheimer's disease development: a comparison of cognitive criteria and associated neuroimaging biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Preclinical AD predicts decline in memory and executive functions in subjective complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Performing label-fusion-based segmentation using multiple automatically generated templates

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

A novel in vivo atlas of human hippocampal subfields using high-resolution 3 T magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Cognitive reserve in ageing and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Reducing between scanner differences in multi-center PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170201

21 January 2018

Identifiers

DOI

10.3233/JAD-170201

1 reference

5 September 2017

1 reference